Hallura Ltd.: Hallura Announces Successful Topline Results of European Multi-Site Clinical Trial with its New BiOLinkMatrix HA Aesthetic Dermal Fillers
The BiOLinkMatrix by HALLURA platform, a new smooth crosslinking method, is the next generation in Hyaluronic Acid (HA) Dermal Fillers offering more natural, safe and elastic-lifting solutions
Ha Afon Kostenloser Wertpapierhandel Stephane Meunier Alona Gellerman Gerhard Sattler Shimon Eckhouse
Source: finanznachrichten.de